Hsieh, A., Pitaressi, J.R., Lerner, J., Donahue, G., Hsiehchen, D., Rustgi, A.K., Zaret, K.S. (2020) Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors. Science Advances 6, eabc4517. PMC7821900
